Keywords: ADHD; Attention deficit hyperactivity disorder; CGI-I; Clinical Global Impression-Improvement scale; cECT; continuation ECT; CI; Confidence interval; ECT; Electroconvulsive therapy; HR; Hazard ratio; ICD; International Classification of Diseases; OCD; Obs
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ADT; antidepressant treatment; ANCOVA; analysis of covariance; ATRQ; Massachusetts General Hospital Antidepressant Treatment Response Questionnaire; BMI; body mass index; CGI-I; Clinical Global Impressions - Improvement; DSM-IV-TR; Diagnostic and Statis
Keywords: Puerperal disorders; Postpartum depression; Postpartum psychosis; Electroconvulsive therapy treatment outcome; CGI-I; Clinical Global Impressions - Improvement scale; CGI-S; Clinical Global Impressions - Severity scale; CI; Confidence interval; DSM; D
Keywords: ANCOVA; Analysis of covariance; C-CASA; Columbia Classification Algorithm for Suicide Assessment; CGI-I; Clinical Global Impressions - Global Improvement; CGI-S; Clinical Global Impressions - Severity of Illness; CRT; Choice Reaction Time; C-SSRS; Col
Keywords: Functional Gastrointestinal Disorder; Disease Management; Value-Based Health Care; Brain-Gut Interactions; CBT; cognitive behavior therapy; CGI; Clinical Global Impressions Scale; CGI-I; Clinical Global Impressions-Improvement Scale; EDU; education condit
Keywords: ECT; Electroconvulsive therapy; HDRS; Hamilton Depression Rating Scale-21; CGI-I; Clinical Global Impressions Improvement; IMI; imipramine; CPZ; chlorpromazine; SGA; second-generation antipsychotic; TCA; tricyclic antidepressant; SSRI; selective serotonin
Keywords: AE; adverse event; CCK; cholecystokinin; CGI; clinical global impression; CGI-I; clinical global impression-improvement; CGI-S; clinical global impression-severity; ChiCTR; Chinese clinical trial registry; CONSORT; consolidated standards of reporting tria
Keywords: ABC; Aberrant Behavior Checklist; ADI-R; Autism Diagnostic Interview-Revised; ASD; autism spectrum disorder; BPI-01; Behavior Problems Inventory-01; CGI; Clinical Global Impressions; CGI-I; Clinical Global Impressions-Improvement; CGI-S; Clinical Global I
Keywords: AIS; Athens Insomnia Scale; BZDs; benzodiazepine drugs; BZRAs; benzodiazepine receptor agonists; CBT-i; cognitive behavior therapy for insomnia; CCMD; Chinese Classification and Diagnosis of Mental Disease; CGI; Clinical Global Impression; CGI-I; Clinical
Keywords: CGI-I; Clinical Global Impressions-Improvement; CGI-S; CGI-Severity of Illness; C-SSRS; Columbia-Suicide Severity Rating Scale; ITT; intent-to-treat; LOCF; last observation carried forward; LS; least squares; LSMD; least squares mean difference; MADRS; Mo
Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions - Improvement (CGI-S) scale in bipolar and major depressive diso
Keywords: CGI-I; clinician global impression scale of improvement; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition; ICH-GCP; International Conference of Harmonisation for Good Clinical Practice Guidelines; ICC; Intraclass Correlation
Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder: A systematic review of the clinical evidence
Keywords: N-acetylcysteine; Obsessive-compulsive disorder; Nutraceutical; ACC; anterior cingulate cortex; BAI; Beck Anxiety Inventory; CBT; cognitive-behavioral therapy; CGI-I; clinical global impression-severity; CSTC; cortico-striato-thalamo-cortical; dACC;
Real-world data of 197 patients treated with ulipristal acetate for uterine fibroids: PREMYA study French population main outcomes
Keywords: Bleeding; Pain; Quality of life; Ulipristal acetate; Uterine fibroids; French population; CGI-I; Clinical Global Impression-Improvement; PAEC; Progesterone receptor modulator associated endometrial changes; PTBS; Patients' Treatment Benefit Scale; UPA;
Research paperDetermination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder
Keywords: BDI; Beck Depression Inventory; CGI-I; Clinical Global Impressions-Improvement; CI; confidence interval; CID; clinically important difference; CIR; clinically important responder; DSST; Digit Symbol Substitution Test; FAS; full analysis set; MADRS; Mont
Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia
Keywords: ANCOVA; analysis of covariance; CDSS; Calgary Depression Scale Score; CGI-I; Clinical Global Impressions-Improvement; CGI-S; Clinical Global Impressions-Severity; CSF; cerebrospinal fluid; C-SSRS; Columbia-Suicide Severity Rating Scale; GlyT1; glycine tra
Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depression
Keywords: MDD; major depressive disorder; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin-norepinephrine reuptake inhibitor; PAM; positive allosteric modulator; mGluR2; metabotropic glutamate 2 receptor; STAR*D; Sequenced Treatment Alternatives to Rel
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies
Keywords: ABAC-A; Abbreviated Brief Assessment of Cognition in Affective Disorders; ACSA; Amphetamine Cessation Symptom Assessment; ADHD; attention-deficit/hyperactivity disorder; BMI; body mass index; CGI-I; Clinical Global Impressions-Improvement; CMH; Cochran-
A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms
Keywords: 5-HT; serotonin; AE; adverse event; ANCOVA; analysis of covariance; CGI-I; Clinical Global Impressions-Improvement; CGI-S; Clinical Global Impressions-Severity of Illness; DUL; duloxetine; EU; European Union; FAS; full analysis set; GAD; generalized a
ReviewInsights into GABAAergic system deficits in fragile X syndrome lead to clinical trials
Keywords: Fragile X syndrome; GABAA receptor; Targeted treatment; Gaboxadol; Ganaxolone; ADAMS; Anxiety, Depression, and Mood Scale; APRA; Antibody-Positioned RNA Amplification; CGI-I; Clinician's Global Impression-Improvement; EMSA; Electrophoretic Mobility Shift
Associate editor: F. TaraziVortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Keywords: Clinical efficacy; Cognitive dysfunction; Major depressive disorder; Serotonin receptors; Vortioxetine; 5-HT; serotonin (5-hydroxytryptamine); ACh; acetylcholine; ATC; Anatomical Therapeutic Classification; CGI-I; Clinical Global Impression-Improvement; C
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Keywords: ABC; Aberrant Behavior Checklist; AD; Alzheimer's disease; ADCS-ADL; Alzheimer's Disease Cooperative Study - Activities of Daily Living; ADHD; attention deficit hyperactivity disorder; ADL; Activities of Daily Living; ADP; adenosine diphosphate; AE; adv
Moderators of treatment response in adults with ADHD treated with a vitamin-mineral supplement
Keywords: ADHD; Attention-Deficit/Hyperactivity Disorder; CAARS; Conners' Adult ADHD Rating Scales; MADRS; Montgomery-Ã
sberg Depression Rating Scale; GAF; Global Assessment of Functioning; CGI-I; Clinical Global Impression-Improvement; NZSEI; New Zealand Socio-E
Evidence for Pretreatment LICI Deficits Among Depressed Children and Adolescents With Nonresponse to Fluoxetine
Keywords: LICI; GABA; Adolescents; Depression; Fluoxetine; CDRS-R; Children's Depression Rating Scale-Revised; CGI-I; Clinical Global Impression-Improvement; GABA; gamma-aminobutyric acid; ICF; intracortical inhibition; ISI; interstimulus interval; LICI; long-inter
Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS)
Keywords: BPRS; Brief Psychiatric Rating Scale; CP; chlorpromazine; CGI-S; Clinical Global Impressions-Severity scale; CGI-I; Clinical Global Impressions-Improvement scale; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders-IV; DISC1; Disrupted-in-Schizo
Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy
Keywords: CGI-I; Clinical Global Impressions Improvement-scale; CGI-S; Clinical Global Impressions Severity-scale; ECT; electroconvulsive therapy; EEG; electroencephalography; fMRI; functional magnetic resonance imaging; MNI; Montreal Neurological Institute; PD; Pa
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency
Keywords: CB1; cannabinoid receptor 1; CGI-S; Clinical Global Impression Scale; CGI-I; Clinical Global Improvement Scale; Cnbs; cannabis; HPDC; haloperidol decanoate; LAI; long acting injections; OR; odds ratio; Addiction; Cannabis; Psychosis; Psychopharmacotherapy
Psychopharmacology in autism: An update
Keywords: ABC; Aberrant Behavior Checklist; ABC-C; Aberrant Behavior Checklist-Community; ABC-CV; Aberrant Behavior Checklist-Community Version; ABC-I; Aberrant Behavior Checklist-Irritability; ABC-H; Aberrant Behavior Checklist-Hyperactivity Subscale; ADHD; Attent
Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study
Keywords: AE; adverse event; AMTD; adjusted mean treatment difference; CGI-C; Clinical Global Impression of Change; CGI-I; Clinical Global Impression-Improvement; CI; confidence interval; DB; double blind; IRLS; International Restless Legs Scale; ITT; intent to t
Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)
Keywords: Restless Legs Syndrome; Long-term efficacy; Pramipexole; RLS; ESS; CGI-I; PGI-I; SF-36
Modafinil Improves Symptoms of Attention-Deficit/Hyperactivity Disorder across Subtypes in Children and Adolescents
Keywords: ADHD; Attention-deficit/hyperactivity disorder; ADHD-RS-IV; Attention-Deficit/Hyperactivity Disorder Rating Scale-IV; CGI-I; Clinical Global Impression of Improvement; CGI-S; Clinical Global Impression of Severity of Illness; CI; Confidence interval; CPRS
Quetiapine as monotherapy for social anxiety disorder: A placebo-controlled study
Keywords: SAD; Social Anxiety Disorder; BSPS; Brief Social Phobia Scale; CGI-I; Clinical Global Impression of Improvement Scale; CGI-S; Clinical Global Impression Severity Scale; SPIN; Social Phobia Inventory; SDI; Sheehan Disability Inventory; NNT; Number Needed t
Ropinirole in the Treatment of Patients With Restless Legs Syndrome: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Keywords: AE; adverse event; CGI; Clinical Global Impression; CGI-I; CGI Improvement; CGI-S; CGI-Severity of Illness; CI; confidence interval; ECG; electrocardiogram; HADS; Hospital Anxiety and Depression Scale; IRLS; International Restless Legs Scale; ITT; intenti